Cambridge Biomedical Campus – a masterplan for the future

Cambridge University Hospitals and its partners are launching a masterplan for the future, setting out how the Cambridge Biomedical Campus will develop as an international centre for patient care, biomedical research and education.

 

This is the next stage of the expansion of the hospital site – part of the 2020 Vision, which was announced ten years ago in 1999. The campus – home to Addenbrooke’s, the Rosie, and partners – will cover 140 acres rather than the current 70, providing room for extensive new clinical facilities including the Children’s Hospital, expanded services for maternity, neurosciences, and cancer, and the relocated Papworth Hospital. It also includes research labs like the new Medical Research Council Laboratory of Molecular Biology, where world-class scientists can work to push back the boundaries of medical knowledge. The campus will be one of the largest and most internationally-competitive concentrations of health-related talent and enterprise in Europe.

 

Stephen Graves, Director of Corporate Development, says: “Our new masterplan sets out the future of the Cambridge Biomedical Campus and ties it into the future of the city and the region. As well as our expansion, it covers the site’s infrastructure, sustainability and transportation – including important links like the guided bus and the access road. We will also be upgrading existing hospital facilities like outpatients, and providing more single rooms.

 

“With our partners, we’re going to make the Cambridge Biomedical Campus and the services for our patients better for everyone – and the expansion will put us at the forefront of institutions that combine clinical care, teaching and research on one site. I know that patients will benefit, both from the new facilities and from the discoveries that are made.”

The masterplan has been developed by Allies and Morrison and Devereux Architects.

 

 

 

Paul Appleton, from Allies and Morrison, says: “This plan will make the Cambridge Biomedical Campus a world-class example of integrated hospital facilities, biomedical research, and education. The site will have a population equivalent to a small town, so we’ve planned a structure that will help people find their way around whilst reducing travel and energy requirements. We also want to promote social interaction, which will have benefits for education and medical research.”

As well as Addenbrooke’s and the Rosie, organisations currently on the campus include:

• Addenbrooke’s Centre for Clinical Investigation (ACRC and WTCRF)
• Brain Repair Centre
• Cambridge Biomedical Research Centre – part of the NIHR
• Cambridge Institute for Medical Research
• Cambridge University Health Partners
• Cancer Research UK Cambridge Research Institute
• GlaxoSmithKline Clinical Research Unit
• Herschel Smith Centre for Brain and Mind Sciences
• Hutchison/MRC Research Centre
• Institute of Metabolic Science
• Institute for Public Health
• MRC Centre for Protein Engineering
• MRC Laboratory of Molecular Biology
• MRC Mitochondrial Biology Unit
• National Blood and Transplant Service
• Strangeways Research Laboratory
• University of Cambridge School of Clinical Medicine
• West Forvie Centre
• Wolfson Brain Imaging Centre

 

The proposed developments include:

• Papworth Hospital
• Rosie Hospital expansion
• Children’s Hospital
• Comprehensive Cancer Centre
• Emergency Department
• Critical Care
• Theatres capacity
• Neurosciences Centre
• Infectious Diseases Facilities

 

Cambridge University Hospitals’ partners in the development of the Cambridge Biomedical Campus are Countryside Properties, Liberty Property Trust and the Pemberton Trustees. The Addenbrooke’s Access Road and the Cambridgeshire Guided Busway are being developed by Cambridgeshire County Council and supported by Cambridgeshire Horizons.

 

 

Download:

 

 

 

 

 

Back to top